Cargando…

Estimating survival and clinical outcome in advanced non-small cell lung cancer with bone-only metastasis using molecular markers

OBJECTIVES: This retrospective study investigated prognostic factors in advanced non-small cell lung cancer (NSCLC) with bone-only metastasis, and developed a graded prognostic assessment (GPA) model to estimate patient survival. METHODS: The primary endpoint was overall survival. We investigated th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Chunliu, Wei, Jia, Tian, Jia, Ma, Jintao, Liu, Ningbo, Yuan, Zhiyong, Zhao, Lujun, Wang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524192/ https://www.ncbi.nlm.nih.gov/pubmed/34703756 http://dx.doi.org/10.1016/j.jbo.2021.100394

Ejemplares similares

Construction and Verification of Nomogram Model for Lung Adenocarcinoma With ≤ 5 Bone-Only Metastases Basing on Hematology Markers
por: Meng, Chunliu, et al.
Publicado: (2022)

The Impact of Chemosensitivity on the Outcome of Brain Metastases in Small-Cell Lung Cancer: A Retrospective Analysis
por: Ma, Jintao, et al.
Publicado: (2022)

Risk Prediction Model for Synchronous Oligometastatic Non-Small Cell Lung Cancer: Thoracic Radiotherapy May Not Prolong Survival in High-Risk patients
por: Meng, Chunliu, et al.
Publicado: (2022)

Association between Bone Mineral Density and Bone Turnover Markers in Breast Cancer Patients and Bone-Only Metastasis
por: Kundaktepe, Berrin Papila, et al.
Publicado: (2021)

The Addition of Peripheral Blood Inflammatory Indexes to Nomogram Improves the Predictive Accuracy of Survival in Limited-Stage Small Cell Lung Cancer Patients
por: Qi, Jing, et al.
Publicado: (2021)

Clinical outcome for small cell lung cancer patients with bone metastases at the time of diagnosis
por: Gong, Linlin, et al.
Publicado: (2019)

Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance
por: Sun, Xue-Song, et al.
Publicado: (2019)

The influence of the metastasis pattern of mediastinal lymph nodes on the postoperative radiotherapy’s efficacy for the IIIA-pN2 non-small-cell lung cancer: a retrospective analysis of 220 patients
por: Zhang, Baozhong, et al.
Publicado: (2016)

Somatic mutations, clinicopathologic characteristics, and survival in patients with untreated breast cancer with bone-only and non-bone sites of first metastasis
por: Kono, Miho, et al.
Publicado: (2018)

Comparison of the clinicopathological characteristics and prognosis between Chinese patients with breast cancer with bone-only and non-bone-only metastasis
por: Zhang, Li, et al.
Publicado: (2020)

Safety of apatinib plus S-1 for advanced solid tumor as palliative treatment
por: Chen, Siying, et al.
Publicado: (2021)

Prognostic Factors for Patients with Bone-Only Metastasis in Breast Cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2013)

Characterization of bone only metastasis patients with respect to tumor subtypes
por: Parkes, Amanda, et al.
Publicado: (2018)

Prognostic Implications of Molecular Subtypes in Primary Small Cell Lung Cancer and Their Correlation With Cancer Immunity
por: Qi, Jing, et al.
Publicado: (2022)

Advances in cancer pain from bone metastasis
por: Zhu, Xiao-Cui, et al.
Publicado: (2015)

Prognostic Evaluation of Nasopharyngeal Carcinoma with Bone-Only Metastasis after Therapy
por: Lu, Tianzhu, et al.
Publicado: (2016)

Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis
por: Chen, Yunzhen, et al.
Publicado: (2013)

Diagnostic and prognostic nomograms for bone metastasis in small cell lung cancer
por: Liu, Chenan, et al.
Publicado: (2021)

TGFβ1 in Cancer-Associated Fibroblasts Is Associated With Progression and Radiosensitivity in Small-Cell Lung Cancer
por: Zhang, Jiaqi, et al.
Publicado: (2021)

Predictive value of EGF and uPAR for chemoradiotherapy response and survival in patients with esophageal squamous cell carcinoma
por: Chen, Xi, et al.
Publicado: (2020)

Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma
por: Delpech, Yann, et al.
Publicado: (2015)

EGFR tyrosine kinase inhibitor HS-10182 increases radiation sensitivity in non-small cell lung cancers with EGFR T790M mutation
por: Chen, Yang, et al.
Publicado: (2018)

Additional radiation boost to whole brain radiation therapy may improve the survival of patients with brain metastases in small cell lung cancer
por: Sun, Han, et al.
Publicado: (2018)

Prognostic utility of FDG PET/CT and bone scintigraphy in breast cancer patients with bone-only metastasis
por: Park, Soyeon, et al.
Publicado: (2017)

Prognostic value of supraclavicular nodes and upper abdominal nodes metastasis after definitive chemoradiotherapy for patients with thoracic esophageal squamous cell carcinoma
por: Li, Xue, et al.
Publicado: (2017)

Advanced Hepatocellular Carcinoma with Bone Metastases: Prevalence, Associated Factors, and Survival Estimation
por: Guo, Xu, et al.
Publicado: (2019)

Optimizing the treatment mode for de novo metastatic nasopharyngeal carcinoma with bone-only metastasis
por: Lin, Cheng, et al.
Publicado: (2022)

Prediction of bone metastasis in non-small cell lung cancer based on machine learning
por: Li, Meng-Pan, et al.
Publicado: (2023)

Simultaneous integrated dose reduction intensity-modulated radiotherapy effectively reduces cardiac toxicity in limited-stage small cell lung cancer
por: Luo, Jing, et al.
Publicado: (2023)

One Cycle of Concurrent Chemotherapy vs. Two Cycles of Concurrent Chemotherapy With Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer
por: Yu, Hao, et al.
Publicado: (2022)

Prognostic significance of bone only metastasis compared to visceral metastasis in patients with carcinoma cervix treated with platinum-based chemotherapy
por: Mallekavu, Suresh Babu, et al.
Publicado: (2017)

Dissociation of bone formation markers in bone metastasis of prostate cancer.
por: Koizumi, M., et al.
Publicado: (1997)

Nomograms for predicting progression and efficacy of post-operation radiotherapy in IIIA-pN2 non-small cell lung cancer patients
por: Zhang, Baozhong, et al.
Publicado: (2017)

Bone Metastasis as the Only Metastatic Site in a Patient with Pancreatic Cancer following Distal Pancreatectomy
por: Saif, Muhammad Wasif, et al.
Publicado: (2010)

Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis
por: Wu, Yi-Ying, et al.
Publicado: (2010)

Practice Patterns of Treatment Strategy of Limited-Stage Small-Cell Lung Cancer: Survey of Chinese Oncologists
por: Xu, Chang, et al.
Publicado: (2022)

Predictors for survival in patients with bone metastasis of small cell lung cancer: A population-based study
por: Xue, MingFeng, et al.
Publicado: (2021)

High Neutrophil-To-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) Are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer
por: Polk, Nándor, et al.
Publicado: (2022)

Non-seminomatous germ cell tumor with bone metastasis only at diagnosis: A rare clinical presentation
por: Biebighauser, K.C., et al.
Publicado: (2017)

Therapeutic Effect of Chemotherapy Cycle in Nasopharyngeal Carcinoma (NPC) Patients Who Developed Bone-Only Metastasis
por: Nong, Sikai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_btdk6jtqke1papcf12qnl5vcfg